Nexco Analytics is a Swiss-based provider of specialized AI, bioinformatics, and data analysis services for the life sciences sector. Founded in 2021, it offers collaborative, custom analytical solutions for genomics, proteomics, and more.
Nexco Analytics is a Swiss biotechnology research and data services company founded in 2021 on the EPFL campus. The company specializes in artificial intelligence, bioinformatics, and data analytics with a primary focus on life sciences, including genomics, transcriptomics, proteomics, and epigenomics. They provide a range of solutions such as statistical consulting, custom pipeline design, biomarker discovery, and antibody optimization. By employing a multidisciplinary team of data scientists, biologists, and medical professionals, Nexco Analytics delivers tailored, collaborative research tools designed to avoid the limitations of "black box" analysis, utilizing their own intellectual property to process and interpret complex biological datasets.
The firm supports a diverse clientele across academia, biotechnology, and pharmaceutical industries, helping researchers accelerate drug discovery, diagnostic development, and innovation. They emphasize time-efficient and precise NGS data analysis, offering platforms that can process large volumes of sequencing data into actionable insights, sometimes within 24 hours. Their service model is built on intensive collaboration, ensuring that analytical plans are aligned with specific research objectives. With a documented history of contributions to high-impact scientific publications, the company acts as a technical partner for laboratory research, providing expertise that bridges the gap between raw biological data and biological understanding.